unclassified Faecalibacterium: NCBI 2646395, [no rank]

Back to details

  1. Commensal Bacteria:

    • Faecalibacterium species are generally considered commensal bacteria, meaning they are part of the normal microbial community in the human gut and are not typically associated with causing diseases.

  2. Short-Chain Fatty Acid Production:

    • Faecalibacterium is known for its ability to produce short-chain fatty acids, particularly butyrate. Butyrate has been associated with potential benefits for gut health and is an important energy source for colonocytes.

  3. Anti-Inflammatory Properties:

    • Some studies suggest that Faecalibacterium prausnitzii, a well-studied species within the genus, may have anti-inflammatory properties and could play a role in maintaining gut homeostasis.

  4. Association with Health:

    • In general, a reduction in the abundance of Faecalibacterium in the gut microbiota has been observed in certain conditions associated with gut dysbiosis or inflammation. However, the exact role and impact of unclassified Faecalibacterium strains may vary.

Other Sources for more information:

You do not have any samples under this email

📹Video Walkthru of this Page

unclassified Faecalibacterium impacts on other bacteria of the same rank

Other bacteria of the same rank impacting unclassified Faecalibacterium

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.

Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.
Inventions /Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]

Due to AI drones slamming this site, we have added IP blocking on excessive calls. Email us if you get blocked and send this [216.73.216 ]